Skip to content

Prediction of the efficacy of neoadjuvant chemotherapy for head and neck squamous cell(HNSCC) carcinoma through pathomics and radiaomics based on artificial intelligence and machine learning

Prediction of the efficacy of neoadjuvant chemotherapy for head and neck squamous cell(HNSCC) carcinoma through pathomics and radiaomics based on artificial intelligence and machine learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088497
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck squamous cell carcinoma

Interventions

Case series:none

Sponsors

Chongqing University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with squamous cell carcinoma of the head and neck through pathology. 2. Patients aged between 18 and 80 years. 3. Patients who have not undergone any prior antitumor treatment. 4. Patients who are scheduled to undergo at least two cycles of neoadjuvant chemotherapy based on a TP (taxane plus platinum) regimen. 5. Patients who have undergone radiological (CT or MRI) assessment of treatment efficacy after two cycles of chemotherapy."

Exclusion criteria

Exclusion criteria: 1. Patients who do not meet the inclusion criteria. 2. Patients who have not undergone chemotherapy according to the standard TP regimen. 3. Patients who refuse to participate in the study. 4. Patients who, after detailed assessment, are deemed unable to tolerate chemotherapy. 5. Patients who have not undergone radiological assessment within one month after two cycles of neoadjuvant chemotherapy.

Design outcomes

Primary

MeasureTime frame
Model prediction accuracy;

Countries

China

Contacts

Public ContactXi Tang

Chongqing University Cancer Hospital

33479986@qq.com+86 186 8075 4847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026